Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks
The COVID-19 pandemic highlights the risks associated with the collection and processing of human biospecimens with an unknown status for the coronavirus SARS-CoV-2, whether for diagnostic, therapeutic, or research purposes. …